Category Archives: Public Policy

Latest From Public Policy

BIO Commends Supreme Court for Expansive View of Patentability in Bilski Decision

The Biotechnology Industry Organization (BIO) released the following statement in reaction to the Supreme Court’s decision to uphold the lower court’s ruling in Bilski v. Kappos.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

IPWatchdog Blog: “In Search of Technology Transfer Best Practices”

The BIO-AUTM Technology Transfer Symposium panel on The Role of Universities, Biotechnology Companies and Technology Transfer in the Innovation Economy included an active debate on issues ranging from increasing the odds for a successful partnership and the pros and cons of the Bayh-Dole Act.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Policy Leaders Discuss U.S. Innovation Economy at BIO-AUTM Technology Transfer Symposium

Today’s Technology Transfer Symposium’s panel on The Role of Universities, Biotechnology Companies and Technology Transfer in the Innovation Economy included an active debate on issues ranging from increasing the odds for a successful partnership and the pros and cons of the Bayh-Dole Act.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Business Success Stories:Video

Three Madison Wisconsin biotech/biomedical businesses discuss what makes their business successful in the Madison Region–from a startup (FluGen), a business just about to enter clinical trials (Quintessence) and a global headquarters with an IPO (TomoTherapy).

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

BIO Announces New Policy on Options for Increasing Access to Medicines in the Developing World

BIO Announces New Policy on Options for Increasing Access to Medicines in the Developing World.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,